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Overexpression of KCNJ3 gene splice
variants affects vital parameters of the
malignant breast cancer cell line MCF-7 in
an opposing manner
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Abstract
Background: Overexpression the KCNJ3, a gene that encodes subunit 1 of G-protein activated inwardly rectifying
K+ channel (GIRK1) in the primary tumor has been found to be associated with reduced survival times and increased
lymph node metastasis in breast cancer patients.
Methods: In order to survey possible tumorigenic properties of GIRK1 overexpression, a range of malignant mammary
epithelial cells, based on the MCF-7 cell line that permanently overexpress different splice variants of the KCNJ3 gene
(GIRK1a, GIRK1c, GIRK1d and as a control, eYFP) were produced. Subsequently, selected cardinal neoplasia associated
cellular parameters were assessed and compared.
Results: Adhesion to fibronectin coated surface as well as cell proliferation remained unaffected. Other vital parameters
intimately linked to malignancy, i.e. wound healing, chemoinvasion, cellular velocities / motilities and angiogenesis
were massively affected by GIRK1 overexpression. Overexpression of different GIRK1 splice variants exerted differential
actions. While GIRK1a and GIRK1c overexpression reinforced the affected parameters towards malignancy,
overexpression of GIRK1d resulted in the opposite. Single channel recording using the patch clamp technique revealed
functional GIRK channels in the plasma membrane of MCF-7 cells albeit at very low frequency.
Discussion: We conclude that GIRK1d acts as a dominant negative constituent of functional GIRK complexes present
in the plasma membrane of MCF-7 cells, while overexpression of GIRK1a and GIRK1c augmented their activity. The
core component responsible for the cancerogenic action of GIRK1 is apparently presented by a segment comprising
aminoacids 235–402, that is present exclusively in GIRK1a and GIRK1c, but not GIRK1d (positions according to GIRK1a
primary structure).
Conclusions: The current study provides insight into the cellular and molecular consequences of KCNJ3 overexpression
in breast cancer cells and the mechanism upon clinical outcome in patients suffering from breast cancer.
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Background
Four gene loci within the human genome encode for sub-
units of G-protein activated K+ channels (GIRK1-4). GIRK
subunits form homo- or hetero-tetrameric ion channel
complexes in the plasma membrane, act as classical G-
protein effectors thereby mediating the regulation of cellu-
lar activity and/or excitability via hormones and neuro-
transmitters [1]. So far, known physiological roles of
GIRKs comprise the vegetative regulation of the heartbeat,
pain perception, learning and memory, anxiety behaviour
and reward mechanisms [1]. Also in electrically non-
excitable tissues physiological functions, like pancreatic in-
sulin secretion [2, 3], blood platelet aggregation [4, 5] and
regulation of lipid metabolism in fat cells [6] have been re-
ported. Two of the gene loci encoding GIRK subunits in
humans have been proven to be related to tumorigenesis
and tumor growth: somatic mutations in the KCNJ9 gene
(encoding the GIRK4 subunit) have been identified to in-
duce endocrine renal adenomas that cause primary aldos-
teronism and severe hypertension [7]. Overexpression of
mRNA encoding the GIRK1 subunit, the product of the
KCNJ3 gene, may contribute significantly to the malignant
properties of breast cancers: using expression profiling,
Stringer et al. [8] observed that RNA derived from KCNJ3
was aberrantly and highly overrepresented in primary inva-
sive breast carcinomas when compared to the correspond-
ing healthy breast tissue. GIRK1 mRNA overexpression
correlated both with occurrence and number of lymph
node metastases. Later on, Brevet et al. [9] observed a posi-
tive correlation between the immunohistochemical staining
of GIRK1 in breast tumor specimen and lymph node me-
tastasis and an inverse correlation with overall survival of
the patients. A retrospective study, based on data from 905
invasive breast cancers derived from The Cancer Genome
Atlas (TCGA) confirmed the findings delineated above at
an appreciably larger scale. This corroborates the correl-
ation between KCNJ3 expression and breast cancer pro-
gression [10]. Malignant breast cancer cell lines express
mRNAs encoding GIRK1 (but also GIRK2 and GIRK4)
subunits [11] and several splice variants of the KCNJ3 gene
transcript [12]. In addition, the occurrence of GIRK1 and
GIRK4 protein has been demonstrated in several breast
cancer cell lines, including MCF-7 [12, 13].
Increasing evidence for KCNJ3 expression in cancerous,
compared to normal breast tissue and for its correlation
with disease progression has accumulated. Comparatively
little is known on a possible causal relationship between
KCNJ3 expression, tumorigenesis and cancer progression.
GIRK1 protein may drive benign mammary epithelial cells
(MECs) towards hallmarks of malignancy. In order to in-
vestigate a presumable role of GIRK1 in oncogenesis and
metastasis of MECs, we overexpressed full length human
GIRK1a as well as two splice variants, GIRK1c and
GIRK1d (known to be abundant in breast cancer cells
[12]), in the MCF-7 breast cancer cell line. This cell line
was chosen, as GIRK1 mRNA levels are high, but expres-
sion of the corresponding protein(s) is low [12, 13] with
the prospect to further strengthen potential malignant
predicates due to pronounced overexpression. Analysis and
comparison of selected vital parameters were performed in
order to pinpoint characteristic features of MCF-7 that
were possibly influenced by KCNJ3 overexpression. By
identification of peculiar properties that may be affected,
we anticipated insight into the mechanism(s) how GIRK1
accomplishes its malignant task.
Methods
Solutions (concentrations in mmole/L): Zeroing Bathing
Solution (ZBS)
K+/Asp-(120), KCl (20), MgCl2 (4), NaCl (10), EGTA
−/K+
(10), HEPES− (10), buffered with K+ to pH:7.4. Pipette Fill-
ing Solution (PFS): KCl (153), MgCl2 (4), CaCl2 (1), GdCl3
(0.2), HEPES− (10) buffered with K+ to pH: 7.4. Neutral
buffered formalin (NBF): 10 % formalin, PO4
− (75) buffered
with Na+ to pH:7.0.
Cell culture
MCF-7 cell line was obtained from ATCC (American
Type Culture Collection) and maintained in minimal es-
sential medium (MEM; Gibco, Life Technologies, Grand
Island, NY, USA; Ordering No: 31095_029) supple-
mented with 10 % fetal bovine serum (Sigma Aldrich, St.
Louis, USA, cat.No.: F2442), 1 mmole/L sodium pyru-
vate (Sigma Aldrich; St. Louis, USA, cat.No.: S8636) and
penicillin/streptomycin (100 U.mL−1/100 ng.mL−1;
Sigma Aldrich; St. Louis, USA, cat.No.: P0781) in 5 %
CO2 atmosphere at 37 °C.
Constructs
N-terminal (N-T) fusions of GIRK1a, GIRK1d and GIRK4
with enhanced yellow fluorescence protein (eYFP) and en-
hanced cyan fluorescence protein (eCFP) were expressed
in MCF-7 cells using the pEYFP-C1 and pECFP-C1 based
constructs described in detail in [12]. C-terminal (C-T) fu-
sions of GIRK1a and GIRK1c with eYFP were produced
by cloning the corresponding coding DNA sequence
(CDS) into the plasmid pEYFP-N1 (Clontech Laborator-
ies, Inc., Mountain View, CA, USA) using XhoI and EcoRI
restriction sites. For fluorescence labelling of subcellular
compartments plasmids encoding glycosylphosphatidyinosi-
tol/eCFP (GPIeCFP; for lipid rafts within plasma membrane
[14]) and signal recognition particle receptor ß-subunit/
eCFP (SrßeCFP; for endoplasmic reticulum (ER) [15]) were
used. A vector for mammalian overexpression of fluores-
cence labelled G-protein β/γ subunits was generated by
cloning Gγ2 CDS (Genbank Acc.No.: M37183) into the
multiple cloning site (MCS) B of the pIRES vector (Clon-
tech Laboratories, Inc., Mountain View, CA, USA) via XbaI
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and SalI restriction sites. Subsequently, the CDS of a fusion
protein of eYFP with Gβ1 (Genbank Acc.No.: M313236; N-
terminal with respect to Gβ1) was inserted into MSC B via
NheI and EcoRI restriction sites. Integrity of the construct
was verified by sequencing. Biological activity of fluores-
cence labelled G-protein β/γ subunits was verified by coex-
pression of the corresponding synthetic mRNAs in Xenopus
laevis oocytes and subsequent electrophysiological testing
for their ability to activate coexpressed GIRK ion channels
composed of the GIRK1a and GIRK4 subunits (data not
shown).
Transfection
MCF-7 cells were transfected with the different constructs
using TransFast reagent (Promega, Madison, USA, Cat.
No.: E2341) and studied approx. 24 h after transfection.
For stable transfection, pEYFP-C1 and pEYFP-N1 based
constructs were linearized with AseI and pIRES construct
with SalI, respectively, prior to transfection. Selection was
started by adding 3 mg/mL G418 (Gibco, life technologies,
Grand Island, USA, Ordering No.: 11811031) to the
medium 24 h after the transfection. Single cell sorting was
done two weeks after G418 addition. Individual clones
were chosen by visual inspection using confocal Laser
Scan Microscopy (cLSM). See Additional file 1: Table S1
for list of clonal cell lines that were used for the present
study.
Confocal laser scan microscopy
Fluorescence images of transfected MCF-7 cells were ob-
tained in-vivo using Leica inverted microscope with 63x
H2O immersion objective (NA: 1.20) with attached laser-
scan module (DMIRE2 and TCS SL2; Leica Microsystems,
Heidelberg, Germany) as described previously [12].
qPCR
RNA isolation and cDNA synthesis were performed as
described previously [12]. qPCR has been described in
[16]. Primer sequences were as follows: GIRK1a_f: 5′-G
TGGAAACAACTGGGATGAC-3′; GIRK1a_r: 5′-GTT








Cells were fixed in NBF, embedded in agarose gel (7 %) and
then processed for paraffin embedding. Target retrieval so-
lution (pH: 9.0; Dako, Glostrup, Denmark; Product No:
S236884) heated for 40 min at 150 W in a microwave was
used for antigen retrieval. Slides were then washed in
washing buffer (Dako, Glostrup, Denmark; Product No:
S3006) and incubated with a monoclonal antibody against
GIRK1 (Abcam, Cambridge, UK; cat.No: 119246; 1:50;
clone 3E11). For visualization, the EnVision + dual link re-
agent (rabbit/mouse horse radish peroxidase, Glostrup,
Dako, Denmark; Product No: K406311) was used according
to manufacturer’s protocols. Immunohistochemical staining
was developed by incubation of sections with diamino-
benzidine (DAB; Glostrup, Dako; Product No: K406511) as
a chromogenic substrate. Slides were then washed in Dako
wash buffer, counterstained with Meyer’s hematoxylin (from
the pharmacy of the Medical University of Graz), rinsed in
tap water, dehydrated and mounted with Entellan® (Merck,
Darmstadt, Germany). Sections incubated without primary
antibody served as negative controls.
Analysis of vital parameters of cell lines
In order to avoid possible deviations of vital parameters
that might be due to the cloning procedure itself instead
of differential overexpression of GIRK1 variants, assess-
ment of these parameters was always conducted on
more than one cell line overexpressing identical con-
structs (Additional file 1: Table S1). As no difference in
vital parameters between cell lines expressing identical
GIRK1 variants was observed, these data were pooled
and analyzed collectively. In order to monitor eventual
effects of stable eYFP overexpression alone or of the ma-
nipulation of cellular genome on the vital parameters
tested, all vital assays were performed using both MCF-
7WT and MCF-7eYFP as controls.
Adhesion assay
MCF-7 cells were washed with PBS and plated into each
well of Corning® BioCoat™ Fibronectin 96 Well Clear
Flat Bottom (Corning, NY. USA, Cat No: 354409). Non-
adherent cells were removed 150 min later by washing
with PBS. Adherent cells were fixed with 2 % formalde-
hyde, air dried and stained with 0.1 % crystal violet
(Sigma Aldrich, St.Louis, USA; Cat No: C0775) in PBS.
Bound dye was solubilized with 10 % acetic acid and ab-
sorbance was measured at 550 nm using a plate reader
(Labsystem Mutiskam MS). Cell-free wells served as
blanks.
Proliferation assay
Cells were plated in six well plates and incubated in a cell
culture incubator until reaching 80 % confluency. Prolifer-
ation of the cells were assessed based on the incorporation
of the thymidine analog, 5-bromo-2′-deoxyuridine (BrdU)
into the newly synthesized DNA of replicating cells (dur-
ing S phase). Labeling of DNA was done by adding 10 μL
of BrdU solution directly to each mL of cell culture media.
(APC BrdU flow kit; BD Pharmingen, San Diego, CA,
USA; Cat No: 552598). The treated MCF-7 cells were then
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incubated for 3 h in cell culture incubator. The cells were
then stained with Anti-BrdU APC. 7-AAD (7-Aminoacti-
nomycin D) (DNA binding dye) used in order to define
cell cycle (G1/G0, S, G2/M).
Invasion assay
Corning® BioCoat™ Matrigel® Invasion Chambers (Corn-
ing, NY. USA, Cat No: 354480) were rehydrated in
MEM for 2 h at 37 °C. 1.25x105 cells/mL in 2 mL MEM
(without fetal bovine serum (FBS)) were seeded into the
upper compartment and 2 mL MEM with 5 % FBS as
chemoattractant were added to the lower compartment
of Matrigel. After 24 h incubation in cell culture incuba-
tor, non-invading cells were removed from the upper
surface of the membrane by scrubbing with cotton
tipped swabs. To stain the invading cells, membranes
beneath the insert were cut, fixed with ice-cold metha-
nol and stained with 0.1 % crystal violet. Invading cells
were counted under microscope.
Wound healing assay
Cells were plated into 24 well plates (1x105 cells/well)
and incubated for 24–72 h to achieve a confluent mono-
layer. The cell monolayer was scratched in a straight line
with a pipet tip (VWR, USA; Cat No #53508-910). Deb-
ris was removed by washing the cells once with PBS
followed by adding MEM growth medium. The plate
was put into the cell observer (Zeiss Axiovert 200 M).
Images were taken over the course of 72 h at 1 h inter-
val. ImageJ software was used for analysis of the result-
ing time lapse videos [17].
Motility assay
Cellular velocities and motility coefficients were assessed
by cell observer (Axiovert200M, Zeiss, Germany) over a
time period of 72 h, as described previously [16].
Ex ovo chorioallantoic membrane (CAM) assay
Fertilized white leghorn chicken eggs from local hatch-
ery (Schropper GmbH, Gloggnitz, Austria) were incu-
bated at 37.6 °C and 70 % humidity (J. Hemel Brutgeräte
GmbH & Co KG, Am Buschbach, Germany). The egg shell
was cracked on day 3 of chicken embryo development, the
embryo was decanted to a sterile dish and further incu-
bated as indicated before. On day 10 of cultivation cell
onplants with volumes of 20 μl were applied on vascular
branches of the CAM within sterile silicon rings of 5 mm
diameter (1x106 cells in 10 μl PBS mixed 1:2 with Matri-
gel® (Corning, NY, USA, cat.No: 356237), allowing subse-
quent tumor growth for 3 days [18]. The intensity of the
angiogenic response was analyzed under a stereomicro-
scope according as described previously [19].
Electrophysiology
Single channel recording from MCF-7 cells in the cell at-
tached configuration was performed exactly as described
previously for PIEZO1 mechanosensitive ion channel pro-
tein, but without application of mechanical stress to the
membrane [16].
Statistics
Statistical evaluation was performed using SPSS software
in the SigmaStat environment (SigmaPlot 13.0; Systat
Software GmbH, Erkrath, Germany) or using “R” soft-
ware (version 3.2.1; https://www.r-project.org/). Depending
on variance and distribution of the dataset, the appropriate
tests were performed, as specified in the legends to the
figures.
Results
Characterization of the generated MCF-7 based cell lines
Effective overexpression of GIRK1 protein in the stably
transfected MCF-7 cell lines was verified by several inde-
pendent methods. GIRK1 is an integral membrane pro-
tein with two transmembrane α-helices per subunit;
therefore, the subcellular localization of fluorescent chi-
maeras in membranes is expected to indicate successful
overexpression of the entire protein. Indeed, expression
of C-terminal labelled GIRK1a was different compared to
soluble eYFP alone, GIRK1 being located mostly in the
endoplasmic reticulum (ER) and, to some extent, also in
the plasma membrane, but not in the nucleus. Pure eYFP
distributed evenly within the cytosol and the nucleus, with
the exception of vacuoles (Fig. 1). Localization identical to
C-terminal labelled GIRK1a was also observed for N-
terminal labelled one, indicating that the position of the
fluorophore did not affect the proteins’ synthesis or sub-
cellular localization (Additional file 1: Figure S1). Similar
subcellular localization was observed for the shorter splice
variants GIRK1c and GIRK1d (Fig. 1). In addition to fluor-
escence microscopy, qPCR corroborated overexpression
of mRNAs encoding all GIRK1 variants in the established
cell lines (Fig. 2a; Additional file 1: Figure S2). Since the
epitope recognized by the antibody used is present exclu-
sively in full length GIRK1a, IHC may not be considered a
suitable tool to confirm expression of the GIRK1c/1d as
these splice variants lack the corresponding part of the C-
terminal portion, respectively. Under our experimental
conditions native MCF-7WT cells did not exert detectable
GIRK1a expression in IHC, underscoring the scale of pro-
tein overexpression in MCF-7GIRK1a cells by orders of
magnitude; these results are in line with qPCR results
(Fig. 2a). Finally, IHC clearly demonstrated overexpression
of the protein as well as its subcellular localization
(Fig. 2b). Thereupon we conclude that the cell lines gener-
ated represent valid models to study the biological effect(s)
of GIRK1 variant overexpression in human breast cancer.
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Effects of GIRK1 overexpression on adhesion and
proliferation of MCF-7 cells
Modification of selected cellular vital parameters in cul-
ture by candidate proteins indicates whether a protein
under consideration may act as an oncoprotein causing
and promoting particular features of malignancy [20, 21].
Cell adhesion (Fig. 3) remained unaffected upon overex-
pression of GIRK1a, GIRK1c and GIRK1d variants. When
monitoring cell cycle and proliferation via gated cell sort-
ing, it became evident that the parameters tested where,
for the major part, unaffected (Fig. 4). The exception was
MCF-7GIRK1d, that exerted an increased period between
cell division and start of DNA replication (G0/G1) when
compared to all other groups. This increase was moderate
and statistically significant only by comparison with MCF-
7GIRK1a. The difference is in line with our observation (SR;
AG) that MCF-7GIRK1d cells require longer time intervals
to grow, when compared to the other cell lines under
identical conditions. We conclude that upon GIRK1
overexpression, proliferative signaling remained prac-
tically unchanged in MCF-7 under our experimental
conditions.
GIRK1 overexpression interferes with wound healing and
invasion
Both wound healing and tumor development, two pro-
cesses that may seem unrelated at the first glance, are based
on similar molecular mechanisms and signaling pathways








GIRK Srß overlay transmission
eYFP Srß overlay transmission
Fig. 1 cLSM in-vivo reveals overexpressed GIRK1 protein to localize in a large part to the ER. Horizontal sequences of images show identical cells.
The sequence of channels (from left to right is: eYFP (green)/ eCFP (red)/ overlay / transmission. Scalebar : 15 μm in all images. a Upper sequence:
subcellular localization of GIRK1a, labelled with eYFP at the C-terminus (MCF-7GIRK1a; transient transfection with GpI-eCFP was used as marker for
lipid rafts in the plasma membrane). Lower sequence: subcellular localization of GIRK1a, labelled with eYFP at the C-terminus (MCF-7GIRK1a; transient
transfection with Srß-eCFP was used as ER marker). b Upper sequence: subcellular localization of hGIRK1c, labelled with eYFP at the C-terminus
(MCF-7GIRK1c; transient transfection with Srß-eCFP was used as ER marker). Middle sequence: subcellular localization of hGIRK1d, labelled with eYFP
at the N-terminus (MCF-7GIRK1d; transient transfection with Srß-eCFP was used as ER marker). Lower sequence: subcellular localization of eYFP alone
(MCF-7eYFP; transient transfection with Srß-eCFP was used as ER marker)
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[22]. Wound healing, however, is a rather transient process,
while tumors pursue to evolve and spread. Hence, wound
healing assay was performed to identify additional charac-
teristic vital parameters, potentially affected by GIRK1 ex-
pression. As shown in Fig. 5a the rate of wound closure
was markedly enhanced by overexpression of the full length
GIRK1a protein when compared to control (see also
Additional files 2, 3 and 4). While overexpression of
GIRK1c produced a similar, albeit statistically not signifi-





























Fig. 2 Overexpression of GIRK1 mRNA and protein in the stably
transfected MCF-7 cells assessed by IHC. a Quantification of mRNA
expression encoding different GIRK1 variants via qPCR in stably
transfected cells. Expression was normalized to the expression level
in the MCF-7WT cell line. WT: MCF-7WT; eYFP: data derived from two
cell lines with stably integrated pEYFPN1 vector alone (MCF-7eYFP);
hG1a: data derived from two cell lines overexpressing N-terminal
and two cell lines overexpressing C-terminal fusions of eYFP with
the GIRK1a protein (MCF-7GIRK1a); hG1c: data derived from two cell lines
overexpressing C-terminal fusions of eYFP with the GIRK1c protein (MCF-
7GIRK1c); hG1d: data derived from two cell lines overexpressing N-terminal
fusions of eYFP with the GIRK1d protein (MCF-7GIRK1d). Mean values ±
SEM were plotted (number of experiments is given in parenthesis above
each bar). Statistical significances between groups are indicated. hG1a, as
well as hG1d differs from both WT, as well as from eYFP, statistically
significant at the p < 0.001 level. hG1c differs from both WT, as well
as from eYFP, statistically significant at the p< 0.05 level. Kruskal-Wallis
one way analysis on ranks was used for analysis of statistical significance.
b Detection of GIRK1a protein in stably transfected cells via
immunohistochemistry. Brown: Immunoreactivity. Blue: hematoxylin
stain. Scale bar corresponds to 100 μm throughout. Upper image:














Fig. 3 Surface adhesion of MCF-7 cells is unaffected by GIRK1
overexpression. Quantification of cells adhering to fibronectin
coated substrate via OD550nm. WT: MCF-7
WT; eYFP: MCF-7eYFP; hG1a:
MCF-7GIRK1a; hG1c: MCF-7GIRK1c; hG1d: MCF-7GIRK1d. Mean values ± SEM
were plotted (number of experiments is given in parenthesis above
each bar). The mean values do not differ statistically significantly
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an increase of wound closure rate that was even slightly re-
duced when compared to control (Fig. 5b). Next, the Matri-
gel invasion assay regarded to be indicative for activation of
invasion and metastasis was performed. This assay unveiled
that GIRK1 overexpression affected invasion towards a
chemoattractant in a bimodal manner, depending on the
respective splice variant: overexpression of GIRK1d greatly
reduced the number of cells with invasive phenotype, while
overexpression of GIRK1a and GIRK1c slightly promoted
invasion, although not statistically significant (Fig. 6; see
Additional file 1: Figure S3 for representative micrographs
of all the groups tested). Taken together, both assays un-
cover remarkable differences between the larger, higher
molecular mass, splice variants GIRK1a and GIRK1c, which
significantly promoted wound healing and invasive pheno-






























Fig. 4 Survey of cell cycle and proliferation upon GIRK1 overexpression in MCF-7 cells. a Original results from the assessment of cell cyle using
gated cell sorting according to fluorescence intensities for PerCP-A (x-axis) and APC-A (y-axis) for different experimental groups. % of cells for the
given experiment is stated in respective colors besides the plot. b Statistics for the percentage of time spent in the different phases of the cell cycle
Mean values ± SEM were plotted. N was (in parenthesis behind each experimental group): was: MCF-7WT (8) / MCF-7eYFP (12) / MCF-7GIRK1a (16) /
MCF-7GIRK1d (12) / MCF-7GIRK1d (6). G1/G0 fraction of MCF-7
GIRK1d differs statistically significant at the p < 0.05 level from the one of MCF-7GIRK1a.
One way ANOVA was used for analysis of statistical significance
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Cellular motilities and velocities are affected by GIRK1
overexpression
Both wound healing and Matrigel invasion assays gather
properties of cells related to cell migration in vitro, prolif-
eration, cell/extracellular-matrix and cell/cell interactions
[23, 24]. When cellular velocities were directly quantified
it became evident that average cellular velocities were
greatly augmented upon overexpression of GIRK1a and
GIRK1c, when compared to control (MCF-7eYFP), MCF-
7WT and MCF-7GIRK1d (Fig. 7). Average velocities of MCF-
7GIRK1d cells were indistinguishable from MCF-7WT or
control cells. Similar results were obtained for cellular mi-
gration, as depicted by cellular motility coefficients (MCs)
that were also considerably increased by GIRK1a and
GIRK1c overexpression (see Additional files 5 and 6).
Again, cellular MCs were indistinguishable when MCF-
7GIRK1d, MCF-7WT and control cells were compared
(Fig. 8). In order to rule out the remote possibility that dif-
ferences in average cellular velocities and MCs observed
were produced by differences between individual MCF-7
cell clones, MCF-7WT cells were transiently transfected
with GIRK1a and the corresponding control plasmid.
Time-lapse microscopy revealed that GIRK1a transfected
cells exhibited massively elevated average velocities and
MCs, when compared to control cells (transfected with
eYFP alone) or non-transfected ones (Additional file 1:
Figure S4).
GIRK1 overexpression affects angiogenesis
Induction of angiogenesis represents another peculiar
feature of cancer cells: while absent in normal tissue, ex-
cept for embryogenesis, wound healing and endometrial
cycling, the “angiogenic switch” is permanently turned
on in tumor cells in order to provide tumor associated
neovasculature [21]. To study the potential of the differ-
ent MCF-7 based cell lines to induce angiogenesis, the
CAM assay was performed (Fig. 9). No apparent differ-
ence in macroscopic vascularization scores (MVSs) was
found for GIRK1 overexpressors when compared indi-
vidually to either control (MCF-7eYFP) or MCF-7WT.
MVS was, however, substantially decreased in MCF-
7GIRK1d cells when they are compared to MCF-7GIRK1a
that showed the highest MVSs amongst all the cell lines
studied. This finding suggests that the “angiogenic
switch” becomes down-regulated by GIRK1d overexpres-
sion. Alternatively, GIRK1a overexpression has no effect
or may even increase angiogenesis, when compared to
MCF-7WT cells that have moderate angiogenic activity
per se (see Fig. 9a and as an example, reference [25]).
Are there functional GIRK ion channels in MCF-7 cells?
In order to investigate whether GIRK1 is able to form
functional K+ ion channels in the plasma membrane of
MCF-7 cells, single channel recording was performed.
At present limited information is available on G-protein
coupled receptors (GPCRs) that may activate GIRKs
in the MCF-7 cell line. Therefore we produced a MCF-7
based cell line, permanently overexpressing free G-


















Fig. 5 GIRK1 overexpression affects wound healing rate in a differential
manner, depending on the variant tested. a Representative view of
monolayers at different time intervals after scratching. Scale bars
correspond to 200 μm. Left: control; right: GIRK1a overexpressors.
b Wound healing rates (in % healing per h). WT: MCF-7WT; eYFP:
MCF-7eYFP; hG1a: MCF-7GIRK1a; hG1c: MCF-7GIRK1c; hG1d: MCF-7GIRK1d.
Mean values ± SEM were plotted (number of experiments is given
in parenthesis above each bar). Statistical significances between
groups are indicated. hG1a differs from eYFP statistically significant
at the p < 0.05 level. hG1a differs from hG1d statistically significant
at the p < 0.001 level. hG1c differs from hG1d statistically significant
at the p < 0.01 level. Kruskal-Wallis one way analysis on ranks was used
for analysis of statistical significance
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activate GIRK channels even in the absence of GPCR ac-
tivation (MCF-7Gβγ; Additional file 1: Figure S5) [1]. Gβ/
γ induced K+ channel activity could be observed only in
one single patch out of 53 experiments, making further
experimentation unpromising. Transient overexpression
of GIRK1 and GIRK4 subunits increased the frequency
of observations of this K+ channel activity in MCF-7Gβγ
to some extent, betokening that it had been produced by
GIRK protein expression (Additional file 1: Figure S5).
Of note a K+ channel with comparable properties has
not yet been observed in MCF-7WT cells (Table 1). This
observation suggests that endogenous GIRKs do not dis-
play appreciable activity in the absence of GPCR activa-
tion. In summary we have demonstrated that functional
GIRK ion channels can be formed in MCF-7 cells,
nevertheless their abundancy is, in the absence of ancil-
lary overexpression, apparently very low.
Discussion
Our results clearly corroborate that overexpression of
GIRK1 protein exerts profound effects on wound heal-
ing, chemoinvasion and cellular motility in the MCF-7
breast cancer cell line suggesting a role to promote inva-
sion and metastasis. Induction of angiogenesis was also af-
fected. Most noteworthy is the fact that all vital parameters
affected by GIRK1 overexpression are manipulated in op-
posite direction, depending on the GIRK1 variant tested.
Overexpression of either GIRK1a or GIRK1c reinforces
vital properties of MCF-7 cells towards the malignant
phenotype, while GIRK1d overexpression seemingly coun-
teracts upon the opposite direction. Hence, differential fea-
tures of GIRK1 variant proteins could be responsible for
this antithetical behavior and comparison of their estab-
lished functional properties may provide insight. While
homo- and heterotetrameric K+ channels containing the
full length GIRK1a subunit have lengthily been studied [1],
little is known on the function(s) and essentially nothing
on the possible (patho)physiological role of the smaller
GIRK1c and GIRK1d variants. In the few studies under-
taken so far by several groups using different expression
























Fig. 6 Effects of GIRK1 variant overexpression on chemoinvasion
through Matrigel. a Comprehensive view of fixated cells, stained
with crystal violet, that managed to invade the Matrigel layer (10x
magnification). The Scalebar corresponds to 100 μm for both images.
Upper: MCF-7GIRK1a, lower: MCF-7GIRK1d. b Quantification of the number
of invasive cells after 24 h. WT: MCF-7WT; eYFP: MCF-7eYFP; hG1a: MCF-
7GIRK1a; hG1c: MCF-7GIRK1c; hG1d: MCF-7GIRK1d. Mean values ± SEM were
plotted (number of experiments is given in parenthesis above each
bar). Statistical significant differences between groups are indicated.
hG1d differs from eYFP statistically significant at the p < 0.05 level.
hG1a and hG1c differ from hG1d statistically significant at the p < 0.001
level. Kruskal-Wallis one way analysis on ranks was used for analysis of
statistical significance
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subunits proved themselves to be inactive as ion channels
(despite of expression at the protein level), and, in addition,
entirely silenced both homo- and heterotetrameric GIRK
complexes by acting as dominant negative constituents
(see [12] for functional testing of splice variants and a sub-























































Fig. 7 Effect of GIRK1 variant overexpression on single cell velocities. a Cellular velocities for three representative cells during the entire observation
interval of 72 h. Asterisks denote cell divisions. Upper: MCF-7eYFP; lower: MCF-7GIRK1a. b Graphical representation of mean cellular velocities for different
experimental groups. WT: MCF-7WT; eYFP: MCF-7eYFP; hG1a: MCF-7GIRK1a; hG1c: MCF-7GIRK1c; hG1d: MCF-7GIRK1d. The median value is represented by the
black line within the box, box margins represent 75 and 25 % percentiles, whiskers indicate 90 and 10 % percentiles, values outside the
10–90 % interval are plotted individually as crosses. The grey line represents the mean value. The number of individual cells is given in
parenthesis besides each box. Statistical significant differences between groups are indicated. hG1a, as well as hG1c, differ from both WT,
as well as from eYFP, statistically significant at the p< 0.001 level. hG1d differs from both hG1a, as well as from hG1c, statistically significant at the p< 0.001
level. Kruskal-Wallis one way analysis on ranks was used for analysis of statistical significance
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Fig. 8 Effect of GIRK1 variant overexpression on single cell motility coefficients. a Left panel: Flower plots showing the trajectories of 5 representative
cells for the entire observation interval of 72 h (black line). Starting position of each individual cell was set to zero coordinates (black circle). Grey circles
indicate the positon of an individual cell after 72 h. Right panel: Squared distance as a function of time for the five cells shown to the left (circles; bars
indicate standard error). Solid lines represent a linear fit through the data, resulting in the motility coefficient (MC). Upper: MCF-7eYFP; lower: MCF-7GIRK1a.
b Graphical representation of cellular motility coefficients for different experimental groups. WT: MCF-7WT; eYFP: MCF-7eYFP; hG1a: MCF-7GIRK1a; hG1c:
MCF-7GIRK1c; hG1d: MCF-7GIRK1d. The median value is represented by the black line within the box, box margins represent 75 and 25 % percentiles,
whiskers indicate 90 and 10 % percentiles, values outside the 10–90 % interval are plotted individually as crosses. The grey line represents the
mean value. The number of individual cells is given in parenthesis besides each box. Statistical significant differences between groups are indicated.
hG1a, as well as hG1c, differs from both WT, as well as from eYFP, statistically significant at the p< 0.001 level. hG1d differs from both hG1a, as well as from
hG1c, statistically significant at the p< 0.001 level. Kruskal-Wallis one way analysis on ranks was used for analysis of statistical significance
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the effect of GIRK1d that is contrary to the effect of
GIRK1a overexpression is due to the dominant negative ef-
fect of GIRK1d on the function of GIRK complexes.
Reinforcement of the malignant phenotype via GIRK sig-
naling takes, to some degree, already place in the native
MCF-7WT cell line, where both mRNA and protein have
been shown to exist [12, 13], although at a much smaller
scale when compared to the overexpressors. Overexpres-
sion of GIRK1d might impair endogenous GIRK signaling
in MCF-7WT, weakening cellular behavior related to the ac-
tivation of invasion, metastatic spread and induction of
angiogenesis. At the same time, overexpression of GIRK1a
would enhance and reinforce the biological activities of
preexisting GIRK complexes, in line with the results of the
prevailing study. Also the finding of prolonged G0/G1
period in MCF-7 cells upon GIRK1d overexpression sup-
ports the view of a dominant negative action on endogen-
ous GIRK complexes. The functional role of GIRK1c
overexpression remains, however, enigmatic. Our study re-
veals for the first time a function for the GIRK1c variant,
other than the constitutive negative properties reported in
previous publications. Here we report that the functional
outcome of GIRK1c overexpression rather resembles the
one produced by overexpression of the GIRK1a subunit.
Indeed all variants of GIRK1 comprise the integral trans-
membrane part, including permeation pathway and ion se-
lectivity filter required to catalyze K+ permeation across the
plasma membrane. Hence, truncated splice variants of
GIRK1 may, under our conditions, act as K+ channels, al-
though this has previously never been observed. At present,
biological activities, other than K+ permeation across the
plasma membrane, might mediate the biological effects ob-
served. By alternative splicing, full length mRNA encoding
GIRK1a is composed of three different exons, i.e. exons 1–
3 [26]. GIRK1c mRNA comprises exons 1 and 2, while the
one encoding GIRK1d is assembled from exons 1 and 3
(exon 2 is missing) [12]. At the protein level, GIRK1a con-
tains 501 amino acids. All three GIRK1 variants share
amino acid positions 1–234 at the N-terminus. Due to a
frameshift that prevents translation of exon 3, GIRK1d has
one single additional C-terminal amino acid (glycine; pos-
ition 235). In contrast and due to exon 2, GIRK1c shares
amino acids positions 235–402 with GIRK1a. To sum up,
the difference between GIRK1c and GIRK1d are 167 add-
itional amino acids at the C-terminal of GIRK1c, when
compared to the single additional amino acid 235 of
GIRK1d. Thus, the key to the tumor promoting activity of
GIRK1 must conceivably be located in the amino acid seg-
ment 235–402. It must be mentioned that the subcellular
distribution observed, i.e. the major fraction of GIRK1 pro-
tein remaining within intracellular membranes rather than
in the plasma membrane, is, at the first glance surprising. It

















Fig. 9 GIRK1d overexpression reduces angiogenesis in the CAM assay. a Representative view of cellular onplants and vascularization. The silicone
ring, used to initially stabilize the onplant is also visible. Scale bars correspond to 200 μm for all images. b Macroscopic vascularization scores
(MVS) for the different experimental groups. WT: MCF-7WT; eYFP: MCF-7eYFP; hG1a: MCF-7GIRK1a; hG1c: MCF-7GIRK1c; hG1d: MCF-7GIRK1d. The median
value is represented by the black line within the box, box margins represent 75 and 25 % percentiles, whiskers indicate 90 and 10 % percentiles, values
outside the 10–90 % interval are plotted individually as crosses. The grey line represents the mean value. The statistically significant difference between
MCF-7GIRK1d and MCF-7GIRK1a is indicated (p < 0.05). Kruskal-Wallis one way analysis on ranks was used for analysis of statistical significance
Table 1 Frequency of observations of functional GIRK channels
in the cell lines used
N patches N with GIRKs % with GIRKs
MCF-7WT;a 291 0 0 %
MCF-7Gβγ 53 1 2 %
MCF-7Gβγ*hG1a *hG4 10 2 20 %
a:data from reference [16]
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transient transfection of MCF-7 cells with GIRK1 splice
variants [12]. It has been frequently observed in studies
dealing with GIRK1 synthesis, trafficking, and plasma
membrane insertion that homooligomeric GIRK1 tetra-
meric protein remains mostly located in intracellular mem-
branes whereas heteromeric assembly with other GIRK
isoforms results in partial plasma membrane insertion and
glycosylation of the GIRK1 subunit [27–29]. It was, how-
ever, observed that even in native cells and in the presence
of additional GIRK isoforms as heterooligomerization part-
ners [30–33] at least 64 % of GIRK1 protein remain per-
manently confined to intracellular membranes [32, 34].
Although the (patho)physiological role of intracellular
GIRK1 repositories within the ER of malignant MECs de-
scribed here remains obscured, their existence is in line
with the one generally observed and we can, at present, not
decide whether intracellular or plasma membrane located
GIRK protein is responsible for the effects observed by us.
Also worth mentioning at this point are long noncoding
RNAs (lnRNAs), sometimes even mRNAs, that do not re-
quire protein to be synthesized at all and have been found
to shift the phenotype of cancer cells towards malignancy
[35]. In the current study, however, the overexpressed
mRNAs were devoid of their 3′- and 5′-untranslated
regions (UTRs) which presumably are crucial for such ac-
tivities. Also the fact that IHC gives negative results for
MCF-7WT cells does not allow to rule out GIRK1 protein(s)
as being responsible for the biological effects observed in
wild-type and control MCF-7 cells and to favor the InRNA
hypothesis. As signal transduction molecules such as GIRK
complexes exert their biological activities usually at very
low abundancies, immunoreactivity below detection
threshold cannot be regarded as proof for the absence of
protein. Therefore we favor the hypothesis that the tumor
promoting effect of KCNJ3 overexpression is provoked by
the corresponding protein(s). Searching for a potential li-
aison between GIRK complexes in the plasma membrane,
cancerogenesis and cancer progression, two major connec-
tions are obvious: First, K+ channel proteins have been
found to promote pathophysiological phenotypes respon-
sible for malignant growth of cancer cells in a vast amount
of reports (see [36–39] for review). While some of these
studies have identified K+ channels to enhance prolifera-
tion, others reported on reinforcement of angiogenesis and
cellular motility, as described in the present study [20]. K+
permeation as well as other hitherto unknown functions of
K+ channel proteins (called “moonlighting” functions) had
been found to promote the malignant phenotype [40–43].
The second potential relation of GIRK signalling to cancer
is exclusive amongst K+ channel proteins as GIRK com-
plexes act as direct G-protein effectors. For example,
GPCR/G-protein mediated signalling guides the migration
of metastatic breast tumor cells towards bone tissue that,
in turn, forms spatial and environmental niches promoting
tumor grow in response to factors released by the invaders
[44, 45]. In general terms, pathological GPCR signaling has
long-since been identified as a major target in the develop-
ment of novel therapeutic approaches [46, 47]. As shown
in the prevailing study, GIRK complexes are able to func-
tion as K+ channels, but occur at extremely low abundancy
in MCF-7 cells. Moreover, GIRK activation depends to a
substantial extent on freely available G-protein β/γ dimers,
i.e. GPCR activation. We conclude that the oncogenic po-
tential of GIRK1 overexpression is closely linked to GPCR
signaling. At present we cannot discriminate between an
impact of K+ permeation itself or another, hitherto un-
known biological function. Since also GIRK1c, the subunit
that so far has not been observed to function as an ion
channel, exerts biological activity similar to the one of
GIRK1a, one may favor the latter hypothesis. We can, how-
ever, not rule out the possibility that the GIRK1c subunit is
functional as an ion channel in MCF-7 cells. More experi-
mentation is required to arrive to definite conclusions con-
cerning this aspect.
Conclusions
This is the first study to provide insight into the cellular
and molecular consequences of KCNJ3 overexpression
in breast cancer cells and the mechanism how overex-
pression could translate into the worsened clinical out-
come in breast cancer. Further research should be
devoted to elucidate the molecular chain of events lead-
ing to reinforcement of malignant phenotype by KCNJ3
overexpression observed in this study. Furthermore the
investigation of the suitability of GIRK1 mRNA and∕or
protein as clinical biomarker(s) as well as the usefulness
of the GIRK1 protein as putative therapeutic target be-
comes worth striving for.
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